Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARGLUMIC ACID vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARGLUMIC ACID vs CASIRIVIMAB\IMDEVIMAB: Safety Overview

Metric CARGLUMIC ACID CASIRIVIMAB\IMDEVIMAB
Total FAERS Reports 663 4,248
Deaths Reported 127 137
Death Rate 19.2% 3.2%
Hospitalizations 358 1,351
Average Patient Age 12.6 yrs 54.3 yrs
% Female Patients 52.6% 55.4%
FDA Approval Date Jun 22, 2022 N/A
Manufacturer Navinta LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A